Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 33.43% is 27% above its 5-year average of 26.40%, around the middle of its 5-year range (20.02%–43.83%).
As of the fiscal period ended Friday, July 31, 2026. 13.61% below its 12-month average of 38.69%.
Reported quarterly debt to assets ratio; no daily interpolation. Q3 FY2026 (2026-07-31): 33.43%.
DEBT TO ASSETS RATIO
33.43%
DEBT TO ASSETS RATIO AVG TTM
38.69%
DEBT TO ASSETS RATIO AVG 3Y
29.29%
DEBT TO ASSETS RATIO AVG 5Y
26.40%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-13.61%
CURRENT VS 3Y AVG
+14.11%
CURRENT VS 5Y AVG
+26.63%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+37043.73%
vs the sector median at left
High Tide Inc.
Market Cap
$237.69M
Debt to Assets Ratio
33.43%
TTM Avg
38.69%
3Y Avg
29.29%
5Y Avg
26.40%
Market Cap
$237.25M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$236.00M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$234.54M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$240.97M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| High Tide Inc. (HITI) | $237.69M | 33.43% | 38.69% | 29.29% | 26.40% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $237.25M | 0.15% | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $238.22M | 0.04% | N/A | N/A | N/A |
| Utah Medical Products, Inc. (UTMD)vs › | $236.00M | 0.00% | N/A | N/A | N/A |
| Q32 Bio Inc. (QTTB)vs › | $239.45M | 0.05% | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $234.93M | 0.00% | N/A | N/A | N/A |
| SIGA Technologies, Inc. (SIGA)vs › | $234.54M | 0.00% | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.97M | 0.03% | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $234.26M | 0.01% | N/A | N/A | N/A |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $234.06M | 0.17% | N/A | N/A | N/A |
Debt/Assets
33.4%
Debt/Equity
1.17
Current Ratio
1.50
Interest Coverage
-1.1x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-07-31 | 33.43% |
| 2026-04-30 | 42.68% |
| 2026-01-31 | 43.83% |
| 2025-10-31 | 42.66% |
| 2025-07-31 | 30.87% |
| 2025-04-30 | 27.34% |
| 2025-01-31 | 28.24% |
| 2024-10-31 | 30.30% |
| 2024-07-31 | 27.86% |
| 2024-04-30 | 28.84% |
| 2024-01-31 | 28.73% |
| 2023-12-29 | 31.08% |
| 2023-07-31 | 26.26% |
| 2023-04-30 | 26.22% |
| 2023-01-31 | 24.98% |
| 2022-10-31 | 25.44% |
| 2022-07-31 | 20.41% |
| 2022-04-30 | 20.14% |
| 2022-01-31 | 20.02% |
| 2021-10-31 | 22.51% |
| 2021-07-31 | 22.52% |
| 2021-04-30 | 27.65% |
| 2021-01-31 | 50.77% |
| 2020-10-31 | 67.27% |
| 2020-07-31 | 64.43% |
| 2020-04-30 | 68.14% |
| 2020-01-31 | 70.17% |
| 2019-10-31 | 58.94% |
| 2019-07-31 | 46.89% |
| 2019-04-30 | 38.59% |
| 2019-01-31 | 26.52% |
| 2018-10-31 | 0.23% |
| 2018-07-31 | 0.26% |
| 2017-10-31 | 173.32% |
